Atossa Therapeutics
ATOS
#9234
Rank
HK$0.81 B
Marketcap
HK$6.30
Share price
3.63%
Change (1 day)
-35.20%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -HK$0.23 Billion

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$0.2 Billion, an increase over its 2023 earnings that were of -HK$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.23 Billion12.82%
2024 -HK$0.2 Billion-15.25%
2023 -HK$0.24 Billion11.62%
2022 -HK$0.21 Billion30.84%
2021 -HK$0.17 Billion15.58%
2020 -HK$0.14 Billion3.41%
2019 -HK$0.14 Billion51.16%
2018 -HK$88.74 Million40.41%
2017 -HK$63.2 Million27.54%
2016 -HK$49.56 Million-47.49%
2015 -HK$94.37 Million-17.25%
2014 -HK$0.12 Billion35.91%
2013 -HK$83.91 Million112.3%
2012 -HK$39.53 Million46.53%
2011 -HK$26.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$252.04 B-112,907.30%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$10.37 B-4,742.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
HK$10.01 B-4,581.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-HK$61.01 Million-72.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
HK$0.32 B-245.14%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-HK$0.85 Billion 280.29%๐Ÿ‡บ๐Ÿ‡ธ USA